MEDVF

Medivolve Inc. MEDVF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MEDVF OPGX BIOIF LADX INSD MHTX LRDSF CBGL CEOS IMMB
6M 0.00 % -33.33 % 0.00 % -92.00 % -90.91 % 0.00 % 0.00 % 180.00 % -72.59 % 0.00 %
YTD -66.67 % -33.33 % -92.19 % -93.91 % -90.91 % -88.89 % 0.00 % -6.67 % -88.68 % 0.00 %
1Y -69.23 % -33.33 % -86.84 % -93.48 % -90.91 % -87.50 % 0.00 % 40.00 % -90.22 % 0.00 %
3Y -98.71 % -99.98 % -93.54 % -99.30 % -99.96 % -99.00 % -99.32 % -65.00 % -75.61 % -50.00 %
5Y 3 870.59 % -99.98 % -98.33 % -99.89 % -99.90 % -99.75 % -100.00 % -99.90 % -64.27 % 0.00 %
10Y 31 874.42 % -99.90 % -99.52 % -99.99 % -99.90 % -99.85 % -99.98 % -99.53 % -36.40 % 0.00 %
From the beginning -99.97 % -99.93 % -99.67 % -100.00 % -99.90 % -100.00 % -99.98 % -90.67 % -99.96 % 0.00 %

Dividend

LadRx Corporation